Investigating the role of LSD2 as an epigenetic regulator in Ewing sarcoma

Ewing sarcoma is the second most common solid bone malignancy diagnosed in pediatric and young adolescent populations. Despite aggressive multi-modal treatment strategies, 5-year event-free survival remains at 75% for patients with localized disease and 20% for patients with metastases. Thus, the ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Priyal O., Pishas, Kathleen I., Taslim, Cenny, Selich-Anderson, Julia, Theisen, Emily R., Lessnick, Stephen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570473/
https://www.ncbi.nlm.nih.gov/pubmed/31231465
http://dx.doi.org/10.18632/oncotarget.26988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570473/
https://www.ncbi.nlm.nih.gov/pubmed/31231465
http://dx.doi.org/10.18632/oncotarget.26988

Ejemplares similares